• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抑制血管生成素-2对支气管腺癌生物学特性的影响]

[The influence of inhibiting angiopoietin-2 on the biological characteristics of bronchogenic adenocarcinoma].

作者信息

Li Bailing, Zhang Guanxin, Hou Xiaolei, Yuan Yang, Liu Xiaohong, Gong Dejun, Huang Shengdong

机构信息

Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):561-7. doi: 10.3779/j.issn.1009-3419.2011.07.01.

DOI:10.3779/j.issn.1009-3419.2011.07.01
PMID:21762624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6000270/
Abstract

BACKGROUND AND OBJECTIVE

It is well-known that angiopoietin-2 (Ang-2) plays an important role in the formation of the blood vascular system. Angiopoietin is involved in many diseases about angiogenesis such as tumor, so may have great prospects for the treatment of these diseases. The aim of this study is to evaluate the influence of inhibiting Ang-2 via adeno-associated virus induced RNA interference (RNAi) on the biological characteristics of bronchogenic adenocarcinoma.

METHODS

AAV-Ang-2shRNA driven by H1 promoter was constructed to transfect A549 cell line. Normal and AAV-Null cell line were utilized in the control groups. The influence of RNAi on Ang-2 expression as well as the growth rate, tumorigenic efficiency, proliferation rate, apoptosis, and microvessel density of A549 cell line were analyzed.

RESULTS

In vitro experiment indicated that the Ang-2 expression level (P<0.001) and growth rate (P<0.001) of A549 cell line 48 h transfected with AAV-Ang-2shRNA were significantly lower than those in the normal and AAV-Null cell lines. Cell cycle analysis showed the proliferation index (PI) of normal, AAV-Null, and AAV-Ang-2shRNA transfected A549 cell line were 0.51± 0.43, 0.48 ± 0.29, and 0.26 ± 0.31, respectively, which indicated the PI of AAV-Ang-2shRNA transfected cell line was significantly lower, compared with the normal and AAV-Null cell lines. In vivo experiment exhibited that AAV-Ang-2shRNA transfected cell line possessed a lower mass and volume of tumor relative to two control groups. In addition, the apoptosis index (AI) of AAV-Ang-2shRNA transfected, normal, and AAV-Null cell lines were (5.98 ± 3.11)%, (7.51 ± 4.42)% and (17.06 ± 7.43)% respectively, which manifested that AAV-Ang-2shRNA transfected cell line possessed a higher AI (P=0.005, P=0.007). A lower percentage of PCNA-positive cell was observed in AAV-Ang-2shRNA transfected cell line (92.75 ± 9.7)% as well, compared with the normal (85.8 ± 11.8)% and AAV-Null (69.8 ± 16.5)% cell lines.

CONCLUSIONS

AAV-mediated expression of shRNA significantly reduces concentration of Ang-2 in A549 cell line, lowers proliferation and growth rate and induce .apoptosis of A549 cell line.

摘要

背景与目的

众所周知,血管生成素-2(Ang-2)在血管系统形成中起重要作用。血管生成素参与了许多与血管生成有关的疾病,如肿瘤,因此在这些疾病的治疗中可能具有广阔前景。本研究旨在评估通过腺相关病毒介导的RNA干扰(RNAi)抑制Ang-2对支气管腺癌生物学特性的影响。

方法

构建由H1启动子驱动的AAV-Ang-2shRNA转染A549细胞系。正常细胞系和AAV-Null细胞系作为对照组。分析RNAi对Ang-2表达以及A549细胞系的生长速率、致瘤效率、增殖率、凋亡和微血管密度的影响。

结果

体外实验表明,转染AAV-Ang-2shRNA的A549细胞系48小时后的Ang-2表达水平(P<0.001)和生长速率(P<0.001)显著低于正常细胞系和AAV-Null细胞系。细胞周期分析显示,正常、AAV-Null和转染AAV-Ang-2shRNA的A549细胞系的增殖指数(PI)分别为0.51±0.43、0.48±0.29和0.26±0.31,这表明转染AAV-Ang-2shRNA的细胞系的PI显著低于正常细胞系和AAV-Null细胞系。体内实验显示,相对于两个对照组,转染AAV-Ang-2shRNA的细胞系形成的肿瘤质量和体积更低。此外,转染AAV-Ang-2shRNA、正常和AAV-Null细胞系的凋亡指数(AI)分别为(5.98±3.11)%、(7.51±4.42)%和(17.06±7.43)%,这表明转染AAV-Ang-2shRNA的细胞系具有更高的AI(P=0.005,P=0.007)。与正常细胞系(8个5.8±11.8)%和AAV-Null细胞系(69.8±16.5)%相比,转染AAV-Ang-2shRNA的细胞系中PCNA阳性细胞的百分比也更低(92.75±9.7)%。

结论

AAV介导的shRNA表达显著降低A549细胞系中Ang-2的浓度,降低其增殖和生长速率,并诱导A549细胞系凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/9450122ef983/zgfazz-14-7-561-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/c521ac65d498/zgfazz-14-7-561-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/8d1249889674/zgfazz-14-7-561-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/9450122ef983/zgfazz-14-7-561-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/c521ac65d498/zgfazz-14-7-561-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/8d1249889674/zgfazz-14-7-561-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/6000270/9450122ef983/zgfazz-14-7-561-3.jpg

相似文献

1
[The influence of inhibiting angiopoietin-2 on the biological characteristics of bronchogenic adenocarcinoma].[抑制血管生成素-2对支气管腺癌生物学特性的影响]
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):561-7. doi: 10.3779/j.issn.1009-3419.2011.07.01.
2
[Abnormal expression of angiopoietin-2 associated with invasion, metastasis and prognosis of lung cancer].[血管生成素-2异常表达与肺癌侵袭、转移及预后的关系]
Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16):1261-1266. doi: 10.3760/cma.j.issn.0376-2491.2018.16.015.
3
[Effects of inhibition of ANG-2 expression in Ishikawa cell line].[抑制ANG-2在Ishikawa细胞系中表达的作用]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):249-53. doi: 10.3760/cma.j.issn.1003-9406.2009.03.003.
4
Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.腺相关病毒介导的血管生成素-1和-2表达在大鼠心脏移植血管病变中的常见保护及多样平滑肌细胞效应
Circ Res. 2006 Jun 9;98(11):1373-80. doi: 10.1161/01.RES.0000225987.52765.13. Epub 2006 May 11.
5
Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.莫氏肝癌中血管生成素-2的过表达导致肿瘤灌注增加并诱导关键的血管生成促进基因。
J Nucl Med. 2006 Sep;47(9):1515-24.
6
Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer.血管生成素-1靶向RNA干扰抑制食管癌的血管生成和肿瘤生长。
World J Gastroenterol. 2008 Mar 14;14(10):1575-81. doi: 10.3748/wjg.14.1575.
7
[Specific antitumor effect of adeno-associated virus vector carrying TRAIL gene under the control of hTERT promoter].[人端粒酶逆转录酶启动子调控下携带TRAIL基因的腺相关病毒载体的特异性抗肿瘤作用]
Ai Zheng. 2008 Oct;27(10):1026-33.
8
[Recombinant adeno-associated virus mediated RNA interference of angiogenin expression inhibits cell growth of human lung adenocarcinoma].
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Mar;32(3):188-92.
9
Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.血管生成素1、2及其共同受体Tie2在人胃癌中的表达:对血管生成的影响
J Korean Med Sci. 2006 Apr;21(2):272-8. doi: 10.3346/jkms.2006.21.2.272.
10
Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor.血管生成素-2 抑制舌癌生长而不影响血管内皮生长因子的表达。
Int J Oral Maxillofac Surg. 2011 Jun;40(6):628-32. doi: 10.1016/j.ijom.2010.11.005. Epub 2010 Dec 15.

本文引用的文献

1
Angiopoietin-2: a potential novel diagnostic marker in multiple myeloma.血管生成素 2:多发性骨髓瘤潜在的新型诊断标志物。
Clin Biochem. 2011 Jun;44(8-9):590-5. doi: 10.1016/j.clinbiochem.2011.01.010. Epub 2011 Feb 12.
2
Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.术前血管生成素-2 血清水平:卵巢肿瘤恶性潜能的标志物和上皮性卵巢癌不良预后的标志物。
Int J Gynecol Cancer. 2010 Dec;20(9):1498-505. doi: 10.1111/IGC.0b013e3181f936e3.
3
Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
血管生成与当前癌症治疗的抗血管生成策略。
J Vasc Interv Radiol. 2010 Dec;21(12):1791-805; quiz 1806. doi: 10.1016/j.jvir.2010.08.009. Epub 2010 Oct 27.
4
Targeting the ANGPT-TIE2 pathway in malignancy.针对恶性肿瘤中的 ANGPT-TIE2 通路。
Nat Rev Cancer. 2010 Aug;10(8):575-85. doi: 10.1038/nrc2894.
5
Will antiangiogenic agents be a future for mesothelioma therapy?抗血管生成药物会成为间皮瘤治疗的未来吗?
Curr Med Chem. 2010;17(27):3069-79. doi: 10.2174/092986710791959710.
6
Anti-angiogenic therapy: adapting strategies to overcome resistant tumors.抗血管生成治疗:调整策略以克服耐药肿瘤。
J Cell Biochem. 2010 Oct 15;111(3):543-53. doi: 10.1002/jcb.22764.
7
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.抑制前列腺癌 LuCaP 23.1 肿瘤中的血管生成素-2 可降低肿瘤生长和活力。
Prostate. 2010 Dec 1;70(16):1799-808. doi: 10.1002/pros.21216.
8
Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.血管生成素-2 调节 TIE2 表达的单核细胞中的基因表达,并增强其固有促血管生成功能。
Cancer Res. 2010 Jul 1;70(13):5270-80. doi: 10.1158/0008-5472.CAN-10-0012. Epub 2010 Jun 8.
9
Regulation of the angiopoietin-2 gene by hCG in ovarian cancer cell line OVCAR-3.人绒毛膜促性腺激素对卵巢癌细胞系 OVCAR-3 中血管生成素-2 基因的调控。
Horm Metab Res. 2010 May;42(5):328-33. doi: 10.1055/s-0030-1249021. Epub 2010 Mar 8.
10
Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.非小细胞肺癌患者化疗期间血清血管生成素-1、血管生成素-2及其受体Tie-2水平
Cancer Invest. 2009 Aug;27(7):741-6. doi: 10.1080/07357900802672704.